Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Katowice
Clinical trial register · Poland

Clinical Trials in Katowice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2716 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2716
Studies in scope
all four open statuses
1383
Recruiting now
open to new participants
510
Lead sponsors
across recruiting studies
Top sites
Bialystok 24 Warsaw 23 Krakow 19 Lodz 14 Bydgoszcz 13
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novo Nordisk A/S4 Amgen3 Ascletis Pharma (China) Co., Limited2 Pfizer1
Site location
Bialystok24 Warsaw23 Krakow19 Lodz14 Bydgoszcz13 Lublin13 Gdansk12 Poznan11 Wroclaw10 Katowice10 Gdynia9 Rzeszów5 Zabrze5 Elblag5 Częstochowa4 Ruda Śląska3 Chrzanów3 Dębica3 Stanisławów Pierwszy2 Warszewo2 Biała Podlaska2 Gorzów Wielkopolski2 Grodzisk Mazowiecki2 Ostrów Mazowiecka2 Bielsko-Biala2 Show all 49
All 49 locations
Target enrolment
to

Trials with a site in Katowice

10 of 2716 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Ascletis Pharma (China) Co., Limited
Phase 3
3,003
Biała Podlaska, Bydgoszcz, Częstochowa, Gdansk, Gdynia, Katowice, Krakow, Lodz
2026-08-31
Recruiting
Ascletis Pharma (China) Co., Limited
Phase 3
1,560
Biała Podlaska, Bydgoszcz, Częstochowa, Gdansk, Gdynia, Katowice, Krakow, Lodz
2026-08-28
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bialystok, Bydgoszcz, Dębica, Katowice, Krakow, Poznan, Rzeszów, Warsaw
2026-05-21
Active, closed
Pfizer
Phase 3
1,078
Lodz, Bialystok, Bydgoszcz, Chojnice, Częstochowa, Gdansk, Gdynia, Katowice
2026-02-24
Active, closed
Novo Nordisk A/S
Phase 3
300
Bialystok, Katowice, Lublin, Warsaw
2025-11-05
Active, closed
Amgen
Phase 3
12,800
Bialystok, Bielsko-Biala, Bydgoszcz, Chojnice, Chrzanów, Dębica, Gdynia, Katowice
2025-07-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Bialystok, Bydgoszcz, Chrzanów, Elblag, Gdansk, Gdynia, Giżycko, Katowice
2025-06-25
Active, closed
Amgen
Phase 3
3,853
Bialystok, Dębica, Gdynia, Katowice, Lodz, Lublin, Poznan, Warsaw
2025-03-12
Active, closed
Novo Nordisk A/S
Phase 4
500
Wroclaw, Gdansk, Katowice, Lodz, Rzeszów, Stanisławow Pierwszy Nieporet, Warsaw, Zabrze
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bydgoszcz, Krakow, Legnica, Lublin, Warsaw, Bialystok, Gdansk, Katowice
2022-11-01
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-poland/city/katowice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,716 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Katowice that also match the filters currently applied.

How many clinical trials are recruiting in Katowice?

4 of the 10 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Katowice), 10 studies
PhaseStudiesRecruitingShare
Phase 39490%
Phase 41010%

Most active sponsors

Lead sponsors with the most studies (Katowice)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S41
Amgen31
Ascletis Pharma (China) Co., Limited22
Pfizer10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.